Loading clinical trials...
Loading clinical trials...
This study is a randomized controlled trial and the purpose of this study is to compare the effects of reciprocal inhibition versus post facilitation muscle energy technique along with conventional physical therapy in patients with piriformis syndrome in terms of pain, range of motion at hip joint and functional disability.
This study aims to compare the effects of reciprocal inhibition with post facilitation muscle energy technique along with conventional physical therapy in terms of pain, functional disability and range of motion at hip joint in patients with piriformis syndrome to find the best suitable and effective treatment for it based on the outcomes. Males and females between the age of 20-50 years, having buttock pain of ≥ 3 on NPRS since 3 months or more and a score of ≥ 8 on a 12-point clinical scoring system as well as any two of the positive screening tests will be recruited in this study as patients of piriformis syndrome. These subjects will be selected via non-probability purposive sampling technique, followed by randomization into two groups using blocked randomization method. A total of 6 treatment sessions will be given to each participant over the duration of 2 weeks with a total of 3 follow-ups after every 2 sessions. TENS and hot pack followed by reciprocal inhibition technique will be given to the experimental group A, while the active comparator group B will be given TENS and hot pack followed by post-facilitation muscle energy technique. Both the groups will be guided about the strengthening exercises given as a home plan.
Age
20 - 50 years
Sex
ALL
Healthy Volunteers
No
Foundation University College of Physical Therapy
Rawalpindi, Punjab Province, Pakistan
Start Date
May 31, 2024
Primary Completion Date
January 15, 2025
Completion Date
January 30, 2025
Last Updated
August 2, 2024
44
ESTIMATED participants
Reciprocal Inhibition MET
OTHER
Post-facilitation MET
OTHER
Conventional physical therapy
OTHER
Lead Sponsor
Foundation University Islamabad
NCT07473349
NCT06530862
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06435169